These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 14432867)
1. [Therapeutic trial of a vasodilator in arteriopathy of the extremities. Evaluation of results and discussion on the use of vasodilators in arteritis]. PIERRON J Mars Med; 1960; 97():641-5. PubMed ID: 14432867 [No Abstract] [Full Text] [Related]
2. [Importance of a new synthetic vasodilator, Caa 40, in the treatment of chronic ulcers of the lower extremities]. THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE JOSSERAND Bull Soc Fr Dermatol Syphiligr; 1959; 66():217-21. PubMed ID: 13837804 [No Abstract] [Full Text] [Related]
3. [First notes on the use of a new vasodilator, Caa 40, in leg ulcers]. DUGOIS P; COLOMB L; GAGNAIRE J Bull Soc Fr Dermatol Syphiligr; 1959; 66():213-4. PubMed ID: 13818502 [No Abstract] [Full Text] [Related]
4. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1]. FERRANTE G; GRASS IM; NEGRO G Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372 [No Abstract] [Full Text] [Related]
5. [Place of vasodilators in the treatment of arteritis of the extremities; concerning a new synthetic vasodilator]. FRIEH C; OLIVIER L Lyon Med; 1959 May; 91(21):891-6 passim. PubMed ID: 13666069 [No Abstract] [Full Text] [Related]
6. [Therapeutic results of a new vasodilator in severe circulatory disorders of the lower extremities]. WEGHAUPT K Wien Klin Wochenschr; 1957 Jan; 69(2):31-2. PubMed ID: 13409874 [No Abstract] [Full Text] [Related]
7. A clinical assessment of arlidin in peripheral vascular diseases. SELIGMAN B Scott Med J; 1958 Apr; 3(4):173-5. PubMed ID: 13555941 [No Abstract] [Full Text] [Related]
8. [Clinical application of a new vasodilator drug]. KAINDL F; PARTAN J; POLSTERER P Wien Klin Wochenschr; 1956 Mar; 68(11):186-91. PubMed ID: 13338244 [No Abstract] [Full Text] [Related]
9. Vasodilators and the use of cyclospasmol in peripheral vascular disease. MAHL MM Angiology; 1961 Sep; 12():432-4. PubMed ID: 13765381 [No Abstract] [Full Text] [Related]
10. A quantitative appraisal of the value of vasodilators in occlusive peripheral arterial disease. GILLESPIE JA Bull Soc Int Chir; 1962; 21():69-72. PubMed ID: 13898634 [No Abstract] [Full Text] [Related]
12. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy]. STARACE G; NOFERI A; PADULA R Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815 [No Abstract] [Full Text] [Related]
13. Effect of nylidrin hydrochloride on the skin and muscle temperature of patients with occlusive arterial disease of the lower extremities. ROEDLING HA; ROTH GM; SCHIRGER A; GIFFORD RW Angiology; 1960 Apr; 11():130-2. PubMed ID: 14438272 [No Abstract] [Full Text] [Related]
14. [Treatment of peripheral vascular diseases with a new vasodilator agent]. MARINONI E; ZUCCHI C Minerva Cardioangiol; 1960 Dec; 8():597-607. PubMed ID: 13766848 [No Abstract] [Full Text] [Related]
18. [Dilatropon in the treatment of peripheral vascular diseases]. FABI M Arcisp S Anna Ferrara; 1959; 12():75-84. PubMed ID: 13821185 [No Abstract] [Full Text] [Related]
19. Peripheral vasodilation: methods of evaluation and the correlation with clinical practice. KAINDI F Angiology; 1960 Feb; 11():15-20. PubMed ID: 14404025 [No Abstract] [Full Text] [Related]
20. [On the use in medical therapy of peripheral arteriopathies of an enzymatic complex in association with a peripheral vasodilator]. STARACE G; NOFERI A Minerva Cardioangiol; 1959 Oct; 7():545-50. PubMed ID: 13833816 [No Abstract] [Full Text] [Related] [Next] [New Search]